CNW/ - Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for ...

We report a 60-year-old male with unresectable HCC who developed Guillain-Barré syndrome (GBS), a rare but severe neurologic complication, after three cycles of sintilimab plus bevacizumab biosimilar ...

Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.

Chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barré syndrome (GBS) are immune-mediated neuropathies. Their pathogenesis involves an immune response to non-protein antigens, ...

Maharashtra has witnessed 224 cases of Guillain-Barre-Syndrome (GBS) and 12 deaths due to it till March 3, Minister of State for Health Prataprao Jadhav told the Rajya Sabha on Tuesday. The ...

Been a few of those lately. Missed the headline, did you? It might look like a Seven and quack like a Seven, but this is in fact a GBS Zero, an altogether different take on the original Lotus ...

Maharashtra reports 12 GBS-related deaths as health officials urge citizens to follow preventive measures. A total of 12 deaths have occurred so far due to GBS in Maharashtra 197 patients diagnosed ...

Mumbai: Maharashtra has reported 225 cases and 12 deaths due to Guillain-Barré Syndrome (GBS), with 197 confirmed cases and 28 under suspicion. According to a report by ANI, the outbreak has led to 12 ...

Pune continues to be plagued by Guillain-Barré Syndrome (GBS) worries, after the 12th suspected GBS death was recorded in Pune district last week. The Pune Municipal Corporation (PMC) survey ...